Renal Cell Carcinoma With Intravascular Venous Tumor Thrombus Articles

Articles

AUA 2016: Identifying mRCC Patients with Venous Thrombus Who Are Likely to Benefit from Cytoreductive Surgery - Session Highlights

San Diego, CA USA (UroToday.com) In this session, Dr. Abel presented his work looking at the ability to predict poor overall survival in patients with metastatic renal cell carcinoma (mRCC) and tumor thrombus. The objective of the study was to determine which patients would be least likely to benefit from cytoreductive nephrectomy (CN) due short post-operative survival.

Published May 6, 2016
Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus, "Beyond the Abstract," by Philippe E. Spiess, MD, MSc, FACS, FRCS(C)

BERKELEY, CA (UroToday.com) - The surgical management of renal cell carcinoma with intravascular venous tumor thrombus requires the commitment of a multidisciplinary surgical team, particularly for higher tumor thrombus extending into the intrahepatic or cardiac segments.

Published January 9, 2013